2024
Cardiac manifestations and outcomes of COVID-19 vaccine-associated myocarditis in the young in the USA: longitudinal results from the Myocarditis After COVID Vaccination (MACiV) multicenter study
Jain S, Anderson S, Steele J, Wilson H, Muniz J, Soslow J, Beroukhim R, Maksymiuk V, Jacquemyn X, Frosch O, Fonseca B, Harahsheh A, Buddhe S, Ashwath R, Thacker D, Maskatia S, Misra N, Su J, Siddiqui S, Vaiyani D, Vaikom-House A, Campbell M, Klein J, Huang S, Mathis C, Cornicelli M, Sharma M, Nagaraju L, Ang J, Uppu S, Ramachandran P, Patel J, Han F, Mandell J, Akam-Venkata J, DiLorenzo M, Brumund M, Bhatla P, Eshtehardi P, Mehta K, Glover K, Dove M, Aldawsari K, Kumar A, Barfuss S, Dorfman A, Minocha P, Yonts A, Schauer J, Cheng A, Robinson J, Powell Z, Srivastava S, Chelliah A, Sanil Y, Hernandez L, Gaur L, Antonchak M, Johnston M, Reich J, Nair N, Drugge E, Grosse-Wortmann L. Cardiac manifestations and outcomes of COVID-19 vaccine-associated myocarditis in the young in the USA: longitudinal results from the Myocarditis After COVID Vaccination (MACiV) multicenter study. EClinicalMedicine 2024, 76: 102809. PMID: 39290640, PMCID: PMC11406334, DOI: 10.1016/j.eclinm.2024.102809.Peer-Reviewed Original ResearchCOVID-19 vaccine-associated myocarditisLate gadolinium enhancementMid-term clinical outcomesVaccine-associated myocarditisCardiac magnetic resonanceMyocardial injuryMulticenter studyClinical diagnosis of acute myocarditisThird dose of mRNA vaccineDiagnosis of acute myocarditisDose of mRNA vaccinePresence of myocardial injuryNo cardiac deathsMedian follow-upCohort multicenter studyMultisystem inflammatory syndromeFollow-up informationCardiac manifestationsAcute myocarditisClinical courseInflammatory syndromeClinical presentationGadolinium enhancementCardiac dysfunctionThird doseCardiac magnetic resonance for ventricular arrhythmias: a systematic review and meta-analysis
Papanastasiou C, Bazmpani M, Kampaktsis P, Zegkos T, Gossios T, Parcharidou D, Kokkinidis D, Tziatzios I, Economou F, Nikolaidou C, Kamperidis V, Tsapas A, Ziakas A, Efthimiadis G, Karamitsos T. Cardiac magnetic resonance for ventricular arrhythmias: a systematic review and meta-analysis. Heart 2024, 110: 1113-1123. PMID: 39084706, DOI: 10.1136/heartjnl-2024-324182.Peer-Reviewed Original ResearchPrevalence of structural heart diseaseCardiac magnetic resonanceStructural heart diseaseVentricular arrhythmiasPrognostic value of cardiac magnetic resonancePresence of late gadolinium enhancementPrognostic evaluation of patientsHeart diseaseNon-ischaemic cardiomyopathyAssociated with increased riskRandom-effects model meta-analysisLate gadolinium enhancementMeta-analysisEvaluation of patientsImprove risk stratificationMyocardial tissue characterisationIschaemic heart diseaseGadolinium enhancementPrognostic implicationsMyocardial inflammationPrognostic valueAdult patientsHypertrophic cardiomyopathyPooled ratePrognostic evaluationElevated myocardial extracellular volume fraction is associated with the development of conduction pathway defects following transcatheter aortic valve replacement
Feroze R, Kang P, Dallan L, Akula N, Galo J, Yoon S, Ukaigwe A, Filby S, Baeza C, Pelletier M, Rushing G, Rajagopalan S, Al‐Kindi S, Rashid I, Attizzani G. Elevated myocardial extracellular volume fraction is associated with the development of conduction pathway defects following transcatheter aortic valve replacement. Catheterization And Cardiovascular Interventions 2024, 104: 1119-1128. PMID: 38952304, DOI: 10.1002/ccd.31136.Peer-Reviewed Original ResearchMeSH KeywordsAction PotentialsAgedAged, 80 and overAortic ValveAortic Valve StenosisArea Under CurveAtrioventricular BlockBundle-Branch BlockCardiac Pacing, ArtificialFemaleFibrosisHeart Conduction SystemHumansMagnetic Resonance Imaging, CineMaleMyocardiumPacemaker, ArtificialPredictive Value of TestsRetrospective StudiesRisk AssessmentRisk FactorsROC CurveTime FactorsTranscatheter Aortic Valve ReplacementTreatment OutcomeConceptsTranscatheter aortic valve replacementCardiac magnetic resonance imagingLate gadolinium enhancementRight bundle branch blockArea under the receiver operating characteristic curveAortic valve replacementReceiver operating curveMyocardial fibrosisPost-TAVRConduction defectsBundle branch blockAssociations of myocardial fibrosisExtracellular volumeConduction diseaseValve replacementGadolinium enhancementPermanent pacemakerConduction abnormalitiesConduction deficitsHeart blockBranch blockRisk of heart blockSeptal late gadolinium enhancementMyocardial extracellular volume fractionBaseline conduction disease
2023
Imaging Acute and Chronic Cardiac Complications of COVID-19 and after COVID-19 Vaccination.
Sánchez Tijmes F, Marschner C, de Matos J, Urzua Fresno C, Gutiérrez Chacoff J, Thavendiranathan P, Fuss C, Hanneman K. Imaging Acute and Chronic Cardiac Complications of COVID-19 and after COVID-19 Vaccination. RadioGraphics 2023, 43: e230044. PMID: 37616171, DOI: 10.1148/rg.230044.Peer-Reviewed Original ResearchConceptsLate gadolinium enhancementGadolinium enhancementCardiac MRICOVID-19 vaccinePattern of late gadolinium enhancementCardiac complications of COVID-19MRNA-based COVID-19 vaccinesPresence of cardiovascular diseaseStress-induced cardiomyopathyMultimodality cardiac imagingBasal inferolateral wallMinority of patientsPersistent cardiac symptomsAdverse cardiovascular eventsComplications of COVID-19Chronic cardiac complicationsManifestations of COVID-19Potential mechanisms of injuryMechanism of injuryCardiovascular manifestations of COVID-19Messenger ribonucleic acidAcute COVID-19Cardiac symptomsCardiovascular manifestationsImaging findingsImpaired left-ventricular global longitudinal strain by feature-tracking cardiac MRI predicts mortality in systemic sclerosis
Feher A, Miller E, Peters D, Mojibian H, Sinusas A, Hinchcliff M, Baldassarre L. Impaired left-ventricular global longitudinal strain by feature-tracking cardiac MRI predicts mortality in systemic sclerosis. Rheumatology International 2023, 43: 849-858. PMID: 36894756, DOI: 10.1007/s00296-023-05294-6.Peer-Reviewed Original ResearchConceptsLate gadolinium enhancementLV-GLSSystemic sclerosisWorse survivalClinical indicationsImpaired left ventricular global longitudinal strainLeft ventricular global longitudinal strainPresence of LGECMR strainLV cardiac indexWorse LV-GLSLV ejection fractionCox regression analysisGlobal longitudinal strainLV cardiac outputGlobal radialCardiac indexOverall survivalRetrospective cohortEjection fractionPrognostic valueAdverse outcomesCardiac outputGadolinium enhancementRV strain
2021
Left atrial evaluation by cardiovascular magnetic resonance: sensitive and unique biomarkers
Peters DC, Lamy J, Sinusas AJ, Baldassarre LA. Left atrial evaluation by cardiovascular magnetic resonance: sensitive and unique biomarkers. European Heart Journal - Cardiovascular Imaging 2021, 23: 14-30. PMID: 34718484, PMCID: PMC8685602, DOI: 10.1093/ehjci/jeab221.Peer-Reviewed Original ResearchConceptsLate gadolinium enhancementAtrial fibrillationCardiovascular magnetic resonanceDiastolic dysfunctionEjection fractionAF recurrenceAtrial fibrosisNew-onset atrial fibrillationPost-operative atrial fibrillationLongitudinal LA strainExtent of fibrosisLong-axis cine imagesCine imagesAtrial imagingCardiovascular eventsLA volumeRisk stratificationAF subjectsPrognostic informationHypertrophic cardiomyopathyLA strainGadolinium enhancementSensitive markerAblation proceduresMagnetic resonance
2020
Differentiation between physiological sport adaptation and hypertrophic cardiomyopathy in highly trained athletes using cardiac magnetic resonance
Czimbalmos C, Nardocci C, Deetjen E, Szabo L, Dohy Z, Toth A, Suhai F, Csecs I, Horvath V, Kiss O, Sydo N, Merkely B, Vago H. Differentiation between physiological sport adaptation and hypertrophic cardiomyopathy in highly trained athletes using cardiac magnetic resonance. European Heart Journal 2020, 41: ehaa946.3119. DOI: 10.1093/ehjci/ehaa946.3119.Peer-Reviewed Original ResearchCardiac magnetic resonance parametersCardiac magnetic resonanceLate gadolinium enhancementDiagnosis of hypertrophic cardiomyopathyHypertrophic cardiomyopathyCut-off valueHCM patientsHealthy athletesPresence of late gadolinium enhancementOptimal cut-off valueCardiac magnetic resonance characteristicsConventional CMR parametersReceiver operating curve analysisDiagnose HCMEnd-diastolic wall thicknessPathological left ventricular hypertrophyOperating curve analysisGlobal longitudinalGadolinium enhancementLV functionVentricular hypertrophyCMR parametersClinical conundrumHypertrophy patternCurve analysisLeft atrial late gadolinium enhancement is associated with atrial fibrillation as detected by continuous monitoring
Bertelsen L, Diederichsen S, Haugan K, Brandes A, Graff C, Krieger D, Kronborg C, Kober L, Peters D, Olesen M, Hojberg S, Vejlstrup N, Svendsen J. Left atrial late gadolinium enhancement is associated with atrial fibrillation as detected by continuous monitoring. European Heart Journal 2020, 41: ehaa946.0308. DOI: 10.1093/ehjci/ehaa946.0308.Peer-Reviewed Original ResearchImplantable loop recorderIncident AFAtrial late gadolinium enhancementLA-LGELate gadolinium enhancementLoop recorderLA volumeLeft ventricularAF episodesGadolinium enhancementLV extracellular volume fractionCardiac magnetic resonance imagingAF ablation proceduresCox regression analysisMultivariable risk prediction modelMagnetic resonance imagingRisk prediction modelExtracellular volume fractionUnknown AFLA fibrosisHazard ratioAtrial fibrillationPrognostic valueAtrial fibrosisRisk factorsHigh-intensity endurance training is associated with left atrial fibrosis
Peritz D, Catino A, Csecs I, Kaur G, Kheirkhahan M, Loveless B, Wasmund S, Kholmovski E, Morris A, Marrouche N. High-intensity endurance training is associated with left atrial fibrosis. American Heart Journal 2020, 226: 206-213. PMID: 32615358, DOI: 10.1016/j.ahj.2020.05.015.Peer-Reviewed Original ResearchConceptsEndurance athletesMaster athletesHigh-intensity endurance trainingTrained endurance athletesNon-athlete controlsHealthy control subjectsLeft atrial fibrosisScreening colonoscopyEndurance trainingAthletic cohortHealthcare complexityAtrial fibrosisAthletesStudy participantsControl subjectsGeneral populationEnduranceQuantify fibrotic changesLeft atrial volumeIncreased atrial fibrosisLeft ventricular functionParticipantsAtrial volumeGadolinium enhancementFibrosis scoreDesmoplakin Cardiomyopathy, a Fibrotic and Inflammatory Form of Cardiomyopathy Distinct From Typical Dilated or Arrhythmogenic Right Ventricular Cardiomyopathy
Smith ED, Lakdawala NK, Papoutsidakis N, Aubert G, Mazzanti A, McCanta AC, Agarwal PP, Arscott P, Dellefave-Castillo LM, Vorovich EE, Nutakki K, Wilsbacher LD, Priori SG, Jacoby DL, McNally EM, Helms AS. Desmoplakin Cardiomyopathy, a Fibrotic and Inflammatory Form of Cardiomyopathy Distinct From Typical Dilated or Arrhythmogenic Right Ventricular Cardiomyopathy. Circulation 2020, 141: 1872-1884. PMID: 32372669, PMCID: PMC7286080, DOI: 10.1161/circulationaha.119.044934.Peer-Reviewed Original ResearchConceptsLV late gadolinium enhancementLate gadolinium enhancementSevere ventricular arrhythmiasAcute myocardial injuryMyocardial injuryRight ventricular cardiomyopathyVentricular arrhythmiasGadolinium enhancementVentricular cardiomyopathyEjection fractionSevere arrhythmiasFrequent premature ventricular contractionsPathogenic plakophilin-2 mutationNormal LV systolic functionLeft ventricle ejection fractionRight ventricular ejection fractionPositron emission tomography scanArrhythmogenic right ventricular cardiomyopathyNormal ventricular functionLV systolic functionVentricle ejection fractionVentricular ejection fractionEmission tomography scanSmall case seriesPlakophilin-2 mutationsP363 Cardiac magnetic resonance characteristics of patients in the grey zone of hypertrophy
Czimbalmos C, Csecs I, Horvath V, Deetjen E, Nardocci C, Dohy Z, Szabo L, Suhai F, Toth A, Sydo N, Kiss O, Merkely B, Vago H. P363 Cardiac magnetic resonance characteristics of patients in the grey zone of hypertrophy. European Heart Journal - Cardiovascular Imaging 2020, 21 DOI: 10.1093/ehjci/jez319.212.Peer-Reviewed Original ResearchLate gadolinium enhancementCardiac magnetic resonancePresence of late gadolinium enhancementHCM patientsHypertrophic cardiomyopathyInter-observer analysisHealthy athletesGadolinium enhancementCardiac magnetic resonance characteristicsStandard deviation of timeConventional CMR parametersMale HCM patientsEnd-diastolic wall thicknessGlobal strain valuesCut-off valueCharacteristics of patientsGray zoneGlobal longitudinalIntraventricular dyssynchronyHypertrophic segmentsCMR parametersDifferential diagnosisDelayed contrastHCM groupPatient group
2019
The Prognostic Role of Late Gadolinium Enhancement in Aortic Stenosis A Systematic Review and Meta-Analysis
Papanastasiou CA, Kokkinidis DG, Kampaktsis PN, Bikakis I, Cunha DK, Oikonomou EK, Greenwood JP, Garcia MJ, Karamitsos TD. The Prognostic Role of Late Gadolinium Enhancement in Aortic Stenosis A Systematic Review and Meta-Analysis. JACC Cardiovascular Imaging 2019, 13: 385-392. PMID: 31326491, DOI: 10.1016/j.jcmg.2019.03.029.Peer-Reviewed Original ResearchConceptsLate gadolinium enhancementAortic stenosisCardiac magnetic resonanceCause mortalityGadolinium enhancementLGE-CMRSystematic reviewA Systematic ReviewStrongest univariate predictorsRandom-effects modelBaseline characteristicsHazard ratioPrognostic roleRisk stratificationAdverse outcomesPrognostic valueUnivariate predictorsPooled analysisMyocardial fibrosisInclusion criteriaCardiac diseaseRegional fibrosisPatientsElectronic databasesMeta-AnalysisMyocarditis with checkpoint inhibitor immunotherapy: case report of late gadolinium enhancement on cardiac magnetic resonance with pathology correlate
Gallegos C, Rottmann D, Nguyen VQ, Baldassarre LA. Myocarditis with checkpoint inhibitor immunotherapy: case report of late gadolinium enhancement on cardiac magnetic resonance with pathology correlate. European Heart Journal - Case Reports 2019, 3: yty149. PMID: 31020225, PMCID: PMC6439394, DOI: 10.1093/ehjcr/yty149.Peer-Reviewed Case Reports and Technical NotesLate gadolinium enhancementCardiovascular magnetic resonanceCardiac complicationsGadolinium enhancementAnti-programmed cell death protein 1 monoclonal antibodyCell death protein 1 monoclonal antibodyLeft ventricular ejection fractionNon-ischemic patternAcute heart failureCheckpoint inhibitor therapyRefractory cardiogenic shockCarotid artery dissectionCheckpoint inhibitor immunotherapyVentricular ejection fractionArea of myocardiumCardiac magnetic resonanceDirect histological correlationAreas of LGEArtery dissectionCardiogenic shockCheckpoint inhibitorsImmunosuppressive therapyVentricular dysfunctionEjection fractionHeart failurePrognostic and functional implications of left atrial late gadolinium enhancement cardiovascular magnetic resonance
Quail M, Grunseich K, Baldassarre LA, Mojibian H, Marieb MA, Cornfeld D, Soufer A, Sinusas AJ, Peters DC. Prognostic and functional implications of left atrial late gadolinium enhancement cardiovascular magnetic resonance. Journal Of Cardiovascular Magnetic Resonance 2019, 21: 2. PMID: 30602395, PMCID: PMC6317232, DOI: 10.1186/s12968-018-0514-3.Peer-Reviewed Original ResearchConceptsLA late gadolinium enhancementNew-onset atrial arrhythmiasLate gadolinium enhancementAtrial arrhythmiasAtrial late gadolinium enhancementLA functionAtrial fibrillationGadolinium enhancementCardiovascular magnetic resonance imagingNew atrial arrhythmiasPoor procedural outcomesLV diastolic functionLA ejection fractionVentricular mechanical functionCardiovascular magnetic resonanceMagnetic resonance imagingSeptal eDiastolic functionEjection fractionHazard ratioLA volumeProcedural outcomesPrognostic biomarkerCardiac diseasePrior history
2018
Assessment of diastolic function and atrial remodeling by MRI – validation and correlation with echocardiography and filling pressure
Seemann F, Baldassarre LA, Llanos‐Chea F, Gonzales RA, Grunseich K, Hu C, Sugeng L, Meadows J, Heiberg E, Peters DC. Assessment of diastolic function and atrial remodeling by MRI – validation and correlation with echocardiography and filling pressure. Physiological Reports 2018, 6: e13828. PMID: 30187654, PMCID: PMC6125607, DOI: 10.14814/phy2.13828.Peer-Reviewed Original ResearchConceptsLate gadolinium enhancementMagnetic resonance imagingPulmonary capillary wedge pressureLA late gadolinium enhancementCapillary wedge pressureTransthoracic echocardiographyDiastolic functionDiastolic parametersWedge pressureAtrial remodelingFilling pressureCardiovascular magnetic resonance imagingLeft atrial remodelingVentricular filling pressureAtrial late gadolinium enhancementLGE-magnetic resonance imagingDiastolic dysfunctionMedical chartsLA volumeAtrial fibrosisGadolinium enhancementResonance imagingPressure catheterizationLow interobserverEchocardiography
2017
Circumferential strain acquired by CMR early after acute myocardial infarction adds incremental predictive value to late gadolinium enhancement imaging to predict late myocardial remodeling and subsequent risk of sudden cardiac death
Holmes A, Romero J, Levsky J, Haramati L, Phuong N, Rezai-Gharai L, Cohen S, Restrepo L, Ruiz-Guerrero L, Fisher J, Taub C, Di Biase L, Garcia M. Circumferential strain acquired by CMR early after acute myocardial infarction adds incremental predictive value to late gadolinium enhancement imaging to predict late myocardial remodeling and subsequent risk of sudden cardiac death. Journal Of Interventional Cardiac Electrophysiology 2017, 50: 211-218. PMID: 29143170, DOI: 10.1007/s10840-017-0296-9.Peer-Reviewed Original ResearchMeSH KeywordsAgedAnalysis of VarianceAngioplasty, Balloon, CoronaryCohort StudiesContrast MediaDeath, Sudden, CardiacFemaleFollow-Up StudiesGadoliniumHumansMagnetic Resonance Imaging, CineMaleMiddle AgedMyocardial InfarctionPredictive Value of TestsProspective StudiesRadiographic Image EnhancementRisk AssessmentROC CurveST Elevation Myocardial InfarctionTime FactorsVentricular RemodelingConceptsAcute myocardial infarctionSudden cardiac deathLate gadolinium enhancementCardiac magnetic resonancePercutaneous coronary interventionWall motion scorePrimary endpointAdverse remodelingLate remodelingMyocardial remodelingCardiac deathMicrovascular obstructionMyocardial infarctionGadolinium enhancementSegmental wall motion scoreCircumferential strainAdverse myocardial remodelingIncremental predictive valueIncremental predictive informationEchocardiography 3Coronary interventionSCD riskResultsA totalLGE volumeSubsequent risk
2015
Effects of delayed-release dimethyl fumarate on MRI measures in the phase 3 CONFIRM study
Miller D, Fox R, Phillips J, Hutchinson M, Havrdova E, Kita M, Wheeler-Kingshott C, Tozer D, MacManus D, Yousry T, Goodsell M, Yang M, Zhang R, Viglietta V, Dawson K, Fox R, Phillips J, Hutchinson M, Havrdova E, Kita M, Wilson K, Yang M, Dawson K, Antel J, Ware J, Polman C, Kowey P, Chung R, Bakris G, Richert J, Seibert B, Brandes D, Brassat D, Cohen B, Diem R, Goldman M, Herndon R, Miller A, Tumani H, Alfaro-Vidal T, Crespo C, Foster J, Hunter K, Garcia-Gomez A, MacManus D, Miller D, Santana V, Tozer D, Wheeler-Kingshott C, Yousry T, Kneebone C, Fedulau A, Likhachev S, Mikhailova E, Naumova H, Decoo D, Gaer L, Sindic C, Grgic S, Sinanovic O, Suljic E, Deleva N, Georgiev D, Haralanov L, Ivanova S, Manchev I, Minchev D, Stamenova P, Tournev I, Vacheva E, Zahariev Z, Bar-Or A, Blevins G, Kremenchutzky M, Veloso F, Witt N, Vargas Howell R, Vindas A, Habek M, Rudež J, Soldo-Butković S, Vurdelja R, Doležil D, Havrdova E, Nova'k J, Vaclavik D, Antsov K, Gross-Paju K, Haldre S, Palu A, Toomsoo T, Al Khedr A, Camu W, Debouverie M, Defer G, De Seze J, Labauge P, Moreau T, Pelletier J, Rumbach L, Daskalovska V, Angnstwurm K, Benes H, Berthele A, Boldt H, Christopher A, Derfuß T, Eisensehr I, Emrich P, Feneberg W, Hoffmann F, Hohlfeld R, Hüntemann R, Kallmann B, Kieseier B, Landefeld H, Lüer W, Masri S, Nelles G, Oschmann P, Paschen C, Reifschneider G, Sailer M, Schimrigk S, Spiegel-Meixensberger M, Storch-Hagenlocher B, Tackenberg B, Tiel-Wilck K, Karageorgiou C, Papathanasopoulos P, Thomaides T, Vlaikidis N, Arjundas D, Behari M, Ghosh A, Ghosh P, Ichaporia N, Khurana D, Kulkarni R, Kumar S, Mehndiratta M, Mehta N, Misra U, Mukherji J, Nellikunja S, Salem A, Sethi P, Shah S, Singh G, Singh M, Singh Y, Srinivasa R, Vijayan K, Hutchinson M, Sweeney B, Gilad R, Shahien R, Paegle A, Delgado C, Escamilla J, Estañol B, Lopez M, Macias M, Punzo G, Quiñones S, Renteria M, Santos J, Gavriliuc M, Groppa S, Odainic O, Timmings P, Czlonkowska A, Dorobek M, Drozdowski W, Fryze W, Hertmanowska H, Kaminska A, Kapelusiak-Pielok M, Kleczkowska M, Kochanowicz J, Losy J, Nowacki P, Nyka W, Pierzchala K, Podemski R, Potemkowski A, Selmaj K, Stelmasiak Z, Szczudlik A, Tutaj A, Wajgt A, Zielinski T, Balasa R, Ionescu-Dimancea V, Mihancea P, Popescu C, Protosevici L, Miletić Drakulić S, Nadj C, Raicevic R, Vojinovic S, Kahancová E, Kurca E, Lisý L, Turčáni P, Arroyo R, Fernández O, Guijarro C, Izquierdo G, Lopez F, Montalbán X, Oreja-Guevara C, Prieto J, Buchakchyys'ka N, Chmyr G, Goloborodko A, Kobys T, Kushnir G, Lebedynets V, Lytvynenko N, Moskovko S, Nehrych T, Palamar B, Pasyura I, Ryabichenko T, Voloshina N, Apperson M, Applebee A, Asher S, Ayala R, Ayres D, Azizi S, Baker M, Bauer B, Bomprezzi R, Buckler R, Carlini W, Chinea A, Cohan S, Crowell G, Edwards K, Eubank G, Felton W, Fodor P, Foley J, Ford C, Fox E, Fox R, Forester M, Freedman S, Garmany G, Gazda S, Giang D, Glaun B, Gold S, Gottesman M, Gudesblatt M, Herbert J, Herskowitz A, Honeycutt W, Huddlestone J, Hull R, Hunter S, Hutton G, Jacobs D, Janicki M, Khatri B, Kinkel R, Kita M, Krolczyk S, Krupp L, LaGanke C, Levin M, Licht J, Luzzio C, Lynch S, Mattson D, Mikol D, Miller T, Minagar A, Mitchell G, Moses H, Negroski D, Newman S, Pardo G, Patel M, Perel A, Phillips J, Picone M, Rammohan K, Rao T, Rinker J, Sadiq S, Schaeffer J, Sheremata W, Shin R, Shubin R, Silverman S, Smith R, Stein L, Stein M, Steiner D, Steingo B, Sullivan H, Sunter W, Vaishnav A, Vasquez A, Voci J, Warach J, Weinstock-Guttman B, Williams M, Wray S. Effects of delayed-release dimethyl fumarate on MRI measures in the phase 3 CONFIRM study. Neurology 2015, 84: 1145-1152. PMID: 25681448, PMCID: PMC4371413, DOI: 10.1212/wnl.0000000000001360.Peer-Reviewed Original ResearchConceptsRelapsing-remitting multiple sclerosisDelayed-release dimethyl fumarateMagnetization transfer ratioLesion activityEffects of delayed-release dimethyl fumarateMultiple sclerosisVolume of T2-hyperintensityActive lesion countsSubcutaneous glatiramer acetatePlacebo-controlled studyMRI lesion activityT2 hyperintense lesionsDimethyl fumarateMagnetization transfer ratio changesT1-hypointense lesionsYear of treatmentClass I evidenceInflammatory lesion activitySafety of DMFDMF BIDDMF therapyOral fumarateGd+ lesionsGadolinium enhancementGlatiramer acetateMultimodality Imaging of Cardiac Sarcoidosis
Blankstein R, Miller E. Multimodality Imaging of Cardiac Sarcoidosis. 2015, 51-72. DOI: 10.1007/978-3-319-14624-9_7.ChaptersCardiac sarcoidosisCardiac MRIImaging testsHigh negative predictive valueExtra-cardiac diseasePreferred imaging testLate gadolinium enhancementFuture adverse eventsNegative predictive valueActive myocardial inflammationImmunosuppressive therapyCardiac involvementMyocardial inflammationAdverse eventsExcellent prognosisClinical criteriaReliable reference standardGadolinium enhancementSarcoidosisPredictive valueMultimodality imagingPatientsTherapyMRIDiagnosisLeft atrial volume, congestive heart failure, and obesity are associated with extent of left atrial fibrosis by late gadolinium enhancement
Grunseich K, Mekonnen B, Simprini L, Mojibian H, Marieb M, Atteya G, Cornfeld D, Peters D. Left atrial volume, congestive heart failure, and obesity are associated with extent of left atrial fibrosis by late gadolinium enhancement. Journal Of Cardiovascular Magnetic Resonance 2015, 17: p368. PMCID: PMC4328531, DOI: 10.1186/1532-429x-17-s1-p368.Peer-Reviewed Original Research
2013
Aortic injury is common following pulmonary vein isolation
Tung P, Hong SN, Chan RH, Peters DC, Hauser TH, Manning WJ, Josephson ME. Aortic injury is common following pulmonary vein isolation. Heart Rhythm 2013, 10: 653-658. PMID: 23318348, DOI: 10.1016/j.hrthm.2013.01.012.Peer-Reviewed Original ResearchConceptsPulmonary vein isolationVein isolationAortic blood poolPercent of patientsNumber of patientsCardiac magnetic resonanceLate gadolinium enhancementSignificant increaseAortic injuryEsophageal injuryAortic enhancementMediastinal structuresGadolinium enhancementPatientsControl groupAortaClinical implicationsHyperenhancementMean signal intensityBlood poolLGELatter groupLA enhancementInjuryLarger LA
This site is protected by hCaptcha and its Privacy Policy and Terms of Service apply